177 related articles for article (PubMed ID: 38240165)
1. Role of the CCL5 and Its Receptor, CCR5, in the Genesis of Aldosterone-Induced Hypertension, Vascular Dysfunction, and End-Organ Damage.
Costa RM; Cerqueira DM; Bruder-Nascimento A; Alves JV; Awata WMC; Singh S; Kufner A; Prado DS; Johny E; Cifuentes-Pagano E; Hawse WF; Dutta P; Pagano PJ; Ho J; Bruder-Nascimento T
Hypertension; 2024 Apr; 81(4):776-786. PubMed ID: 38240165
[TBL] [Abstract][Full Text] [Related]
2. Role Of The C-C Motif Chemokine Ligand 5 (CCL5) And Its Receptor, C-C Motif Chemokine Receptor 5 (CCR5) In The Genesis Of Aldosterone-induced Hypertension, Vascular Dysfunction, And End-organ Damage.
Costa RM; Cerqueira DM; Bruder-Nascimento A; Alves JV; Awata WAC; Singh S; Kufner A; Cifuentes-Pagano E; Pagano PJ; Ho J; Bruder-Nascimento T
bioRxiv; 2023 Sep; ():. PubMed ID: 37790434
[TBL] [Abstract][Full Text] [Related]
3. CCR5 antagonist treatment inhibits vascular injury by regulating NADPH oxidase 1.
Singh S; Bruder-Nascimento A; Belin de Chantemele EJ; Bruder-Nascimento T
Biochem Pharmacol; 2022 Jan; 195():114859. PubMed ID: 34843718
[TBL] [Abstract][Full Text] [Related]
4. The CCL5/CCR5 Axis Promotes Vascular Smooth Muscle Cell Proliferation and Atherogenic Phenotype Switching.
Lin CS; Hsieh PS; Hwang LL; Lee YH; Tsai SH; Tu YC; Hung YW; Liu CC; Chuang YP; Liao MT; Chien S; Tsai MC
Cell Physiol Biochem; 2018; 47(2):707-720. PubMed ID: 29794461
[TBL] [Abstract][Full Text] [Related]
5. HIV Protease Inhibitor Ritonavir Impairs Endothelial Function Via Reduction in Adipose Mass and Endothelial Leptin Receptor-Dependent Increases in NADPH Oxidase 1 (Nox1), C-C Chemokine Receptor Type 5 (CCR5), and Inflammation.
Bruder-Nascimento T; Kress TC; Kennard S; Belin de Chantemèle EJ
J Am Heart Assoc; 2020 Oct; 9(19):e018074. PubMed ID: 33003981
[TBL] [Abstract][Full Text] [Related]
6. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
[TBL] [Abstract][Full Text] [Related]
7. ACKR2 contributes to pulmonary dysfunction by shaping CCL5:CCR5-dependent recruitment of lymphocytes during influenza A infection in mice.
Tavares LP; Garcia CC; Gonçalves APF; Kraemer LR; Melo EM; Oliveira FMS; Freitas CS; Lopes GAO; Reis DC; Cassali GD; Machado AM; Mantovani A; Locati M; Teixeira MM; Russo RC
Am J Physiol Lung Cell Mol Physiol; 2020 Apr; 318(4):L655-L670. PubMed ID: 31995405
[TBL] [Abstract][Full Text] [Related]
8. Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension.
Mikolajczyk TP; Nosalski R; Szczepaniak P; Budzyn K; Osmenda G; Skiba D; Sagan A; Wu J; Vinh A; Marvar PJ; Guzik B; Podolec J; Drummond G; Lob HE; Harrison DG; Guzik TJ
FASEB J; 2016 May; 30(5):1987-99. PubMed ID: 26873938
[TBL] [Abstract][Full Text] [Related]
9. Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer.
Sax MJ; Gasch C; Athota VR; Freeman R; Rasighaemi P; Westcott DE; Day CJ; Nikolic I; Elsworth B; Wei M; Rogers K; Swarbrick A; Mittal V; Pouliot N; Mellick AS
Oncotarget; 2016 Dec; 7(51):85437-85449. PubMed ID: 27863423
[TBL] [Abstract][Full Text] [Related]
10. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.
Raghu H; Lepus CM; Wang Q; Wong HH; Lingampalli N; Oliviero F; Punzi L; Giori NJ; Goodman SB; Chu CR; Sokolove JB; Robinson WH
Ann Rheum Dis; 2017 May; 76(5):914-922. PubMed ID: 27965260
[TBL] [Abstract][Full Text] [Related]
11. Augmented CCL5/CCR5 signaling in brown adipose tissue inhibits adaptive thermogenesis and worsens insulin resistance in obesity.
Chan PC; Hung LM; Huang JP; Day YJ; Yu CL; Kuo FC; Lu CH; Tian YF; Hsieh PS
Clin Sci (Lond); 2022 Jan; 136(1):121-137. PubMed ID: 34821367
[TBL] [Abstract][Full Text] [Related]
12. CCL5 derived from platelets increases megakaryocyte proplatelet formation.
Machlus KR; Johnson KE; Kulenthirarajan R; Forward JA; Tippy MD; Soussou TS; El-Husayni SH; Wu SK; Wang S; Watnick RS; Italiano JE; Battinelli EM
Blood; 2016 Feb; 127(7):921-6. PubMed ID: 26647394
[TBL] [Abstract][Full Text] [Related]
13. Genetic Polymorphism at
Batista AM; Alvarado-Arnez LE; Alves SM; Melo G; Pereira IR; Ruivo LAS; da Silva AA; Gibaldi D; da Silva TDESP; de Lorena VMB; de Melo AS; de Araújo Soares AK; Barros MDS; Costa VMA; Cardoso CC; Pacheco AG; Carrazzone C; Oliveira W; Moraes MO; Lannes-Vieira J
Front Immunol; 2018; 9():615. PubMed ID: 29696014
[TBL] [Abstract][Full Text] [Related]
14. NLRP3 Inflammasome Mediates Aldosterone-Induced Vascular Damage.
Bruder-Nascimento T; Ferreira NS; Zanotto CZ; Ramalho F; Pequeno IO; Olivon VC; Neves KB; Alves-Lopes R; Campos E; Silva CA; Fazan R; Carlos D; Mestriner FL; Prado D; Pereira FV; Braga T; Luiz JP; Cau SB; Elias PC; Moreira AC; Câmara NO; Zamboni DS; Alves-Filho JC; Tostes RC
Circulation; 2016 Dec; 134(23):1866-1880. PubMed ID: 27803035
[TBL] [Abstract][Full Text] [Related]
15. Blockade of Autocrine CCL5 Responses Inhibits Zika Virus Persistence and Spread in Human Brain Microvascular Endothelial Cells.
Mladinich MC; Conde JN; Schutt WR; Sohn SY; Mackow ER
mBio; 2021 Aug; 12(4):e0196221. PubMed ID: 34399621
[TBL] [Abstract][Full Text] [Related]
16. Adipose Tissue-Derived CCL5 Enhances Local Pro-Inflammatory Monocytic MDSCs Accumulation and Inflammation via CCR5 Receptor in High-Fat Diet-Fed Mice.
Chan PC; Lu CH; Chien HC; Tian YF; Hsieh PS
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430701
[TBL] [Abstract][Full Text] [Related]
17. CCR5 is involved in resolution of inflammation in proteoglycan-induced arthritis.
Doodes PD; Cao Y; Hamel KM; Wang Y; Rodeghero RL; Kobezda T; Finnegan A
Arthritis Rheum; 2009 Oct; 60(10):2945-53. PubMed ID: 19790057
[TBL] [Abstract][Full Text] [Related]
18. Vascular dysfunction and fibrosis in stroke-prone spontaneously hypertensive rats: The aldosterone-mineralocorticoid receptor-Nox1 axis.
Harvey AP; Montezano AC; Hood KY; Lopes RA; Rios F; Ceravolo G; Graham D; Touyz RM
Life Sci; 2017 Jun; 179():110-119. PubMed ID: 28478264
[TBL] [Abstract][Full Text] [Related]
19. Dose dependent effects of platelet derived chondroitinsulfate A on the binding of CCL5 to endothelial cells.
Weingart C; Nelson PJ; Krämer BK; Mack M
BMC Immunol; 2008 Dec; 9():72. PubMed ID: 19068144
[TBL] [Abstract][Full Text] [Related]
20.
Battaglin F; Baca Y; Millstein J; Yang Y; Xiu J; Arai H; Wang J; Ou FS; Innocenti F; Mumenthaler SM; Jayachandran P; Kawanishi N; Lenz A; Soni S; Algaze S; Zhang W; Khoukaz T; Roussos Torres E; Seeber A; Abraham JP; Lou E; Philip PA; Weinberg BA; Shields AF; Goldberg RM; Marshall JL; Venook AP; Korn WM; Lenz HJ
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38212126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
